Guangzhou Boji Medical and Biotechnological Co Ltd (300404) - Total Liabilities
Based on the latest financial reports, Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has total liabilities worth CN¥569.21 Million CNY (≈ $83.29 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Guangzhou Boji Medical and Biotechnologi to track the company's year-over-year net asset growth rate.
Guangzhou Boji Medical and Biotechnological Co Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Guangzhou Boji Medical and Biotechnological Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Guangzhou Boji Medical and Biotechnologi to measure how efficiently the company converts operating cash flow to free cash.
Guangzhou Boji Medical and Biotechnological Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangzhou Boji Medical and Biotechnological Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Delpha Construction Co Ltd
TW:2530
|
Taiwan | NT$20.39 Billion |
|
Shenzhen Bestek Technology Co Ltd
SHE:300822
|
China | CN¥304.40 Million |
|
MSC Income Fund, Inc.
NYSE:MSIF
|
USA | $690.40 Million |
|
Pilani Investment and Industries Corporation Limited
NSE:PILANIINVS
|
India | Rs37.87 Billion |
|
Beijing Tieke Shougang Railway Tech Co Ltd
SHG:688569
|
China | CN¥564.81 Million |
|
Actblue Co Ltd
SHE:300816
|
China | CN¥1.46 Billion |
|
Arvinas Inc
NASDAQ:ARVN
|
USA | $284.00 Million |
|
YLZ Information Tech Co
SHE:300096
|
China | CN¥478.84 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Guangzhou Boji Medical and Biotechnological Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Guangzhou Boji Medical and Biotechnologi.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangzhou Boji Medical and Biotechnological Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2025)
The table below shows the annual total liabilities of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥569.88 Million ≈ $83.39 Million |
+26.97% |
| 2024-12-31 | CN¥448.84 Million ≈ $65.68 Million |
+0.00% |
| 2023-12-31 | CN¥448.82 Million ≈ $65.68 Million |
+19.14% |
| 2022-12-31 | CN¥376.71 Million ≈ $55.12 Million |
+29.08% |
| 2021-12-31 | CN¥291.83 Million ≈ $42.70 Million |
+10.28% |
| 2020-12-31 | CN¥264.64 Million ≈ $38.72 Million |
+49.51% |
| 2019-12-31 | CN¥177.00 Million ≈ $25.90 Million |
-2.91% |
| 2018-12-31 | CN¥182.31 Million ≈ $26.68 Million |
+13.68% |
| 2017-12-31 | CN¥160.37 Million ≈ $23.47 Million |
+80.17% |
| 2016-12-31 | CN¥89.01 Million ≈ $13.02 Million |
+1.76% |
| 2015-12-31 | CN¥87.47 Million ≈ $12.80 Million |
-4.70% |
| 2014-12-31 | CN¥91.78 Million ≈ $13.43 Million |
+4.16% |
| 2013-12-31 | CN¥88.12 Million ≈ $12.89 Million |
+39.78% |
| 2012-12-31 | CN¥63.04 Million ≈ $9.22 Million |
-- |
About Guangzhou Boji Medical and Biotechnological Co Ltd
Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch … Read more